
Pharmaceuticals
Developing innovative medicines for patients, creating value for healthcare providers
Developing innovative medicines for patients, creating value for healthcare providers
Pioneering evidence-based therapies, delivering better access for users
Focusing on areas of great human suffering with wider societal implications
MAY 10, 2022
One Pill Can Kill – Fentanyl Awareness Day May 10
APRIL 28, 2022
Interim Report Q1 - Promising start to 2022
APRIL 27, 2022
Orexo´s partner Gesynta Pharma granted Orphan Drug Designation by the FDA for OX-MPI - systemic sclerosis
Orexo is listed on Nasdaq Stockholm´s mainlist, Mid Cap, (ORX), and can be traded on the US market, via an ADR on OTCQX Market (ORXOY).
It’s always a good time to check that your #epinephrine #autoinjector is in date and that you, and your loved ones,… https://t.co/ngoSG8sWdj
Economic disruptions due to COVID-19, such as job loss, led to a sharp decrease in #addiction treatment among peopl… https://t.co/O62fOwFrkr
🎥DISCOVER OUR STORY 💠Where have we come from? 💠How have we evolved? 💠What motivates us to do what we do? To leahttps://t.co/KHhuWDIHpFIHpF
Group net revenues
LTM1
Group EBITDA
LTM1
US Pharma segment EBIT
LTM1
Cash position
Q1 2022
1 Last Twelve Months, Q221-Q122, for more information about financial development Link